Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen

Rikke Andersen, Marco Donia, Troels Holz Borch, +8

Clinical Cancer Research

Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer

Manja Idorn, Tania Køllgaard, Per Kongsted, +2

Cancer Immunology Immunotherapy

UrologyGenitourinary CancerMedicineNegative Prognostic MarkersMalignant Blood Disorder +5

Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study

Per Kongsted, Troels Holz Borch, Trine Zeeberg Iversen, +6

Cytotherapy

VaccinationUrologyDendritic Cell VaccinationMedicineImmunology +7

T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression

Rikke Andersen, Troels Holz Borch, Arianna Draghi, +15

Annals of Oncology

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

Mads Duus Hjortsø, Stine Kiær Larsen, Per Kongsted, +8

OncoImmunology

Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma

Troels Holz Borch, Katja Harbst, Aynal Haque Rana, +14

Journal for ImmunoTherapy of Cancer

Predictors of Chemotherapy-Induced Toxicity and Treatment Outcomes in Elderly Versus Younger Patients With Metastatic Castration-Resistant Prostate Cancer

Per Kongsted, Inge Marie Svane, Henriette Lindberg, +1

Clinical Genitourinary Cancer

UrologyOncologyGeriatric OncologyGeriatricsCancer Management +6

Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: Is there a clinical benefit?

Per Kongsted, Inge Marie Svane, Henriette Lindberg, +2

Urologic Oncology Seminars and Original Investigations

UrologyGenitourinary CancerMedicineLow-dose PrednisolonePharmacotherapy +5

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Andreas Lundqvist, Vincent van Hoef, Xiaonan Zhang, +1756

Journal for ImmunoTherapy of Cancer